Literature DB >> 25737985

Biofilm Producing Multidrug Resistant Acinetobacter baumannii: An Emerging Challenge.

Gitanjali Kailas Badave1, Dhananjay Kulkarni2.   

Abstract

AIM: To study the quantitative method for biofilm formation and examine the correlation between biofilm formation and antibiotic resistance among the clinical isolates of Acinetobacter baumannii.
MATERIALS AND METHODS: A total of 72 A. baumannii isolates from different clinical specimens were processed and confirmed by conventional microbiological methods. Antimicrobial susceptibility testing was performed by Kirby Bauer disc diffusion method using six antibiotics. Biofilm formation was studied by microtitre plate assay.
RESULTS: Forty five (62.5%) of 72 isolates produced biofilm. Resistance to ampicillin-sulbactam was least. 36.1% isolates were resistant to imipenem, 66.6% to ceftazidime, 72.2% to ciprofloxacin, 80.5% to amikacin and 84.7% to piperacillin. Biofilm formers showed greater resistance to ampicillin- sulbactam, amikacin, ciprofloxacin and ceftazidime as compared to imipenem and piperacillin. In all 65 (90.3%) isolates showed multiple drug resistance. Correlation between multidrug resistance and biofilm formation was analysed statistically and p-value was found to be significant (p-value =0.0004; p-value < 0.05 is significant by Chi - Square Test).
CONCLUSION: The study concludes that there a positive correlation between biofilm formation and multiple drug resistance in A. baumannii.

Entities:  

Keywords:  A. baumannii; Antimicrobial susceptibility; Biofilm; BlaPER-1; Exopolysaccharide; Microtitre plate assay; Multiple drug resistance; Nosocomial

Year:  2015        PMID: 25737985      PMCID: PMC4347076          DOI: 10.7860/JCDR/2015/11014.5398

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  21 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices.

Authors:  G D Christensen; W A Simpson; J J Younger; L M Baddour; F F Barrett; D M Melton; E H Beachey
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

Review 4.  Clinical impact and pathogenicity of Acinetobacter.

Authors:  M-L Joly-Guillou
Journal:  Clin Microbiol Infect       Date:  2005-11       Impact factor: 8.067

5.  Survival of Acinetobacter baumannii on dry surfaces.

Authors:  C Wendt; B Dietze; E Dietz; H Rüden
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

6.  The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation.

Authors:  A Toledo-Arana; J Valle; C Solano; M J Arrizubieta; C Cucarella; M Lamata; B Amorena; J Leiva; J R Penadés; I Lasa
Journal:  Appl Environ Microbiol       Date:  2001-10       Impact factor: 4.792

7.  In silico analysis of antibody triggering biofilm associated protein in Acinetobacter baumannii.

Authors:  Mohammad Reza Rahbar; Iraj Rasooli; Seyed Latif Mousavi Gargari; Jafar Amani; Yaser Fattahian
Journal:  J Theor Biol       Date:  2010-06-23       Impact factor: 2.691

Review 8.  Biofilms: survival mechanisms of clinically relevant microorganisms.

Authors:  Rodney M Donlan; J William Costerton
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

9.  Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.

Authors:  H-W Lee; Y M Koh; J Kim; J-C Lee; Y-C Lee; S-Y Seol; D-T Cho; J Kim
Journal:  Clin Microbiol Infect       Date:  2007-11-13       Impact factor: 8.067

10.  Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii.

Authors:  R Srinivasa Rao; R Uma Karthika; S P Singh; P Shashikala; R Kanungo; S Jayachandran; K Prashanth
Journal:  Indian J Med Microbiol       Date:  2008 Oct-Dec       Impact factor: 0.985

View more
  19 in total

1.  Biofilm Production Correlating with Multidrug Resistance Among Clinical Isolates of Acinetobacter baumannii.

Authors:  Venkataramana Kandi
Journal:  J Clin Diagn Res       Date:  2015-06-01

2.  Methods to Evaluate Colistin Heteroresistance in Acinetobacter baumannii.

Authors:  Edgar X Sherman; Jessie E Wozniak; David S Weiss
Journal:  Methods Mol Biol       Date:  2019

3.  Iron/Heme Metabolism-Targeted Gallium(III) Nanoparticles Are Active against Extracellular and Intracellular Pseudomonas aeruginosa and Acinetobacter baumannii.

Authors:  Seoung-Ryoung Choi; Bradley E Britigan; Prabagaran Narayanasamy
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

4.  Significant presence of biofilm-producing gut-derived bacteria in anal fistula of chronic duration.

Authors:  Prakhar Jaiswal; Swati Sharma; Arvind Pratap; Mumtaz Ansari; Vijay K Shukla; Somprakas Basu; Tuhina Banerjee
Journal:  Int Wound J       Date:  2021-02-05       Impact factor: 3.315

5.  A1S_2811, a CheA/Y-like hybrid two-component regulator from Acinetobacter baumannii ATCC17978, is involved in surface motility and biofilm formation in this bacterium.

Authors:  Rong Chen; Ruichen Lv; Lisheng Xiao; Min Wang; Zongmin Du; Yafang Tan; Yujun Cui; Yanfeng Yan; Yanping Luo; Ruifu Yang; Yajun Song
Journal:  Microbiologyopen       Date:  2017-07-17       Impact factor: 3.139

6.  Molecular characterization of β-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii.

Authors:  Kevin M Raible; Bhaswati Sen; Nancy Law; Tiffany E Bias; Christopher L Emery; Garth D Ehrlich; Suresh G Joshi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-11-16       Impact factor: 3.944

7.  Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran.

Authors:  Zahra Farshadzadeh; Farhad B Hashemi; Sara Rahimi; Babak Pourakbari; Davoud Esmaeili; Mohammad A Haghighi; Ali Majidpour; Saeed Shojaa; Maryam Rahmani; Samira Gharesi; Masoud Aziemzadeh; Abbas Bahador
Journal:  Front Microbiol       Date:  2015-10-20       Impact factor: 5.640

8.  Evaluation of Different Phenotypic Techniques for the Detection of Slime Produced by Bacteria Isolated from Clinical Specimens.

Authors:  Rajkumar Hrv; Ramakrishna Devaki; Venkataramana Kandi
Journal:  Cureus       Date:  2016-02-23

9.  Activity of Gallium Meso- and Protoporphyrin IX against Biofilms of Multidrug-Resistant Acinetobacter baumannii Isolates.

Authors:  David Chang; Rebecca A Garcia; Kevin S Akers; Katrin Mende; Clinton K Murray; Joseph C Wenke; Carlos J Sanchez
Journal:  Pharmaceuticals (Basel)       Date:  2016-03-17

10.  Discovery of cahuitamycins as biofilm inhibitors derived from a convergent biosynthetic pathway.

Authors:  Sung Ryeol Park; Ashootosh Tripathi; Jianfeng Wu; Pamela J Schultz; Isaiah Yim; Thomas J McQuade; Fengan Yu; Carl-Johan Arevang; Abraham Y Mensah; Giselle Tamayo-Castillo; Chuanwu Xi; David H Sherman
Journal:  Nat Commun       Date:  2016-02-16       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.